A number of the Dutch firm's products have received certification under Europe's In Vitro Diagnostic Regulation recently.

Roche confirmed its full-year outlook with sales expected to increase in the mid-single-digit percent range at constant exchange rates. The firm added that EPS for full-year 2025 is expected to ...

SSID Group said that the assets acquired in the deal will complement its gastric health portfolio and let it offer a broader range of tests to US labs.

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

The Canadian firm’s SpineStat assay is used to detect autoantibodies to the protein biomarker 14-3-3eta to aid the diagnosis of axial spondyloarthritis.

The company said during a conference call following release of its Q1 2025 results that it purchases roughly 80 percent of its supplies from sources within the US.

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.

NEW YORK – Diagnostics firm Genalyte is laying the groundwork for the commercial launch of its Merlin point-of-care clinical analyzer. The San Diego-based firm has completed its submission to the US ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

The Swiss healthcare firm said that the money will be used to expand its R&D, manufacturing, and distribution operations in the US.

The Australian precision diagnostics firm said it will use the money to support the launch of its proteomic tests in Australia and the US.